Tetherin is part of the cellular innate immunity and impedes cell-free transmission of viruses that bud from the plasma membrane by retaining them on the cell surface. Some viruses have evolved activities in different proteins such as Vpu (HIV-1), K-protein (KSHV), Nef (SIV) or Env (HIV-2) to downregulate tetherin and overcome its restriction. We found that chronically HTLV-1 infected T-cell lines express eightfold more tetherin than uninfected transformed T-cell lines suggesting that tetherin expression is not inhibited by the virus. We observed that even small amounts of exogenous tetherin caused the retention of HTLV-1 on the cell surface and severely reduced cell-free infectivity of HTLV-1, but that cell-cell transmission, which is more relevant for HTLV-1, was significantly less decreased. However, knock-down of tetherin expresssion resulted in a slight increase in cell-cell infection indicating that the protein does not enhance this route of transmission.
Introduction
Many retroviruses achieve rapid dissemination through the release of cell-free virus particles as well as by cell-cell contact (Johnson and Huber, 2002; Mothes et al., 2010; Phillips, 1994; Sattentau, 2008) . Releasing large numbers of stable virions can improve the range and probability of successful transmission to a susceptible target cell through blood, lymph, cerebrospinal and other bodily fluids, but exposes the virus to immune system surveillance and biophysical and kinetic barriers (Sattentau, 2008) . In contrast, cell-cell viral transmission is limited to proximal cell contacts, but potentially benefits the virus by avoiding neutralization by the immune response that would hinder the cell-free virus. Cell-cell transmission may also allow the provirus to regulate gene expression and to focus virion assembly and release to the region of contact. Additionally, accumulation of viral proteins, in particular envelope (Env), in the limited area of cell-cell contact could lead to interaction with receptors and remodulation of the target cells to make viral transmission more efficient (Mothes et al., 2010) .
Human T-lymphotropic virus 1 (HTLV-1) is the causative agent of acute T-cell lymphoma (ATL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) (Gallo and Reitz, 1985; Gessain et al., 1985; Poiesz et al., 1980a Poiesz et al., , 1980b Robert-Guroff et al., 1985) . HTLV-1 infects target cells primarily through cell-cell contact . HTLV-1 is capable of infecting a wide range of cell types as the components of its receptor complex (GLUT-1, neuropilin and heparin sulfate proteoglycans) are ubiquitously expressed (Ghez et al., 2006; Jones et al., 2005; Manel et al., 2005; Swainson et al., 2005) , but T-lymphocytes are the major reservoir of the virus in vivo. No viremia is found in HTLV-1-infected patients in vivo, and although cell-free virus particles can be detected in the supernatant of freshly cultured HTLV-infected-cells, only 1 in 10 5 to 1 in 10 6 of these virions appears to be infectious (Derse et al., 2001; Fan et al., 1992; Majorovits et al., 2008; Nejmeddine and Bangham, 2010) . HTLV-1 infection with cell-free virus is inefficient in vitro (Mazurov et al., 2010) and infectious transmission between individuals is known to require the presence of HTLV-infected lymphocytes in breast milk, semen, or blood products. The precise mechanism of cell-cell infection in vivo is unknown, but two types of cell-cell transmission in vitro have been described. Igakura et al. (2003) first used immunofluorescence microscopy to visualize transmission of HTLV-1 via a cell-cell contact they termed virological synapse (VS). The term was coined because superficially the contact between Env on the infected T-lymphocyte and the virus receptor on the target cell resembled an immunological synapse (IS), which is induced by the interaction between the major histocompatibility complex (MHC) on the antigen presenting cell (APC) and the T-cell receptor (TCR) on the T-cell. Even though different sets of molecules initiate the formation of VS and IS, both synapses have segregated microdomains of talin and the microtubule organization center (MTOC) is oriented toward cell-cell contact (Davis et al., 2003) . However, the MTOC of the producer cell reorients towards the VS Barnard et al., 2005) . This is in contrast to the reorganization of the MTOC towards the clustered TCR in the target T-cell after IS formation. This observation immediately suggested that HTLV-1 induced cytoskeletal polarization in order to transmit viral material to the uninfected cell (Nejmeddine and Bangham, 2010) .
Recently a new type of cell-cell transmission was described, which is based on the observation that some viral particles are stored after budding in the extracellular matrix of the producer cells, which is formed by carbohydrate-rich components and linker cellular proteins (Pais-Correia et al., 2010; Jones and Green, 2010; Thoulouze and Alcover, 2011) . These viral assemblies are transferred to target cells during the interaction between infected and noninfected T-lymphocytes and can be observed on the surface of the cells in multiple sites, even quite distant from cell-cell contact. This mode of transfer does not require any special remodeling in cells; thus the infection can occur quite rapidly. Collagen, agrin, galectin-3, and tetherin are some of the components that form the extracellular matrix trapping the viral particles.
Tetherin is a cellular transmembrane protein with unusual topology: both N-and C-terminal ends are anchored in the membrane via a glycosyl-phosphatidylinositol (GPI) anchor and conventional transmembrane domains, respectively (Kupzig et al., 2003) . The GPI-anchor is responsible for the enrichment of tetherin in lipid rafts. Tetherin, which is also known as BST2 or CD317, was originally identified and cloned in 1995, is expressed on the surface of B-cells, T-cells, monocytes and macrophages, and plasmocytoid dendritic cells (Evans et al., 2010; Ishikawa et al., 1995) . Tetherin has more recently been identified as part of the innate antiviral defense mechanisms based on its ability to tether human immunodeficiency virus (HIV)-1 and other viral particles on the cell surface (Neil et al., 2008; Jouvenet et al., 2009; Van Damme et al., 2008) . Acting nonspecifically, tetherin prevents the release of viral particles, keeping them attached to the membrane of the infected cell (Jouvenet et al., 2009; Perez-Caballero et al., 2009) . The retained viral particles are fully formed and mature, and are eventually endocytosed and degraded (Neil et al., 2006) . Viruses have evolved functions to counteract the tetherin effect; for instance, for most HIV-1 strains the protein Vpu acts as a tetherin antagonist (Strebel et al., 1988) . The mechanism of antitetherin activity of Vpu is not completely defined. It is believed that Vpu directly interacts with tetherin triggering downregulation from the cell surface and further proteosomal or lysosomal degradation Goffinet et al., 2009; Iwabu et al., 2009; Rong et al., 2009; Skasko et al., 2011) . In other viruses the anti-tetherin activity is carried out by other proteins: for most simian immunodeficiency virus (SIV) strains, the function resides in Nef, for HIV-2 in Env, for Kaposi's sarcoma herpes virus (KSHV) in K5 and for other SIV species and Ebola virus in the glycoproteins (Jia et al., 2009; Kaletsky et al., 2009; Le Tortorec and Neil, 2009; Mansouri et al., 2009; Rong et al., 2009; Sauter et al., 2009) .
The inhibitory effect of tetherin on the cell-free spread of viruses is immediately apparent; however, the consequences for cell-cell transmission in the context of the VS or viral assembly models are not as clearly predictable. Early papers suggested that Vpu is not necessary under conditions of cell-to-cell transmission (Gummuluru et al., 2000; Hamm et al., 1999) . More recent studies investigating the effect of tetherin on cell-cell transmission of HIV-1 have reported slight negative or positive effects (Casartelli et al., 2010; Jolly et al., 2010; Kuhl et al., 2010) .
In this paper, we investigated the influence of tetherin on HTLV-1 transmission. We show that HTLV-1 does not have a mechanism to downregulate tetherin from the cellular surface. Indeed, we detected elevated levels of tetherin in chronically HTLV-1-infected T-cell lines. We observed the colocalization of tetherin and virus particles at the site of cell-cell contact, but found that at low to intermediate concentrations tetherin did not have a significant effect (less than twofold) on cell-cell infection. In contrast, cell-free transmission at these concentrations was almost completely restricted. Silencing of tetherin slightly facilitated transmission of virus through the cell-cell contact. In our opinion, HTLV-1 can spread without downregulating tetherin from the cellular membrane by relying on clonal expansion of infected cells and cell-cell transmission.
Results

HTLV-1 particles are restricted by tetherin
In our first experiment, we showed that HTLV-1 particles encoded by a full length proviral construct are retained on 293T cells when tetherin is coexpressed, as has also previously been demonstrated by Jouvenet et al. (2009) . This finding suggests that HTLV-1, which has several accessory genes in addition to gag, pro, pol and env, does not encode a function that is able to counteract tetherin ( Fig. 1 ). As was shown before (Jouvenet et al., 2009 ), addition of an HIV-1 Vpu encoding plasmid to the transfection mix resulted in the efficient release of the virus. Similar experiments performed in HeLa cells showed that the endogenous tetherin did not prevent virus release completely, suggesting that HTLV-1 can overcome lower level expression of tetherin to some extent.
HTLV-1 infected cell lines express higher levels of tetherin than noninfected CD4 þ T-cell lines
To address the question whether HTLV-1 infection affects the expression of tetherin, we compared the expression levels of tetherin protein in seven chronically infected T-cell lines (HUT102, MT2, MS9, MS68, C3669, C8166, Su68) and in four uninfected transformed T-cell lines (Jurkat E6, CEM174, Molt4, H9), as well as in activated uninfected peripheral blood lymphocytes (PBLs) by Western blot analysis. We found that HTLV-1 expressing cells have on average higher steady state levels of tetherin than primary activated PBL or uninfected CD4 þ T-cell lines ( Fig. 2A) . We determined the expression of tetherin relative to that of tubulin by densitometry analysis and found that the average expression level of tetherin (in arbitrary units) in uninfected cells was 15.5712.3 (mean7standard deviation) and HeLa cells transfected with 0.8 mg HTLV-1 plasmid pCMVHT1-M and 0.3 mg plasmid expressing HIV-1 Vpu or empty vector plasmid. HEK293T cells were additionally co-transfected with 0.3 mg of plasmid encoding WT tetherin. Blots were probed with anti-p19MA mAb as described in Materials and Methods (these mAbs are able to recognize unprocessed precursor of Gag (p55) (Heidecker et al., 2004) ). compared to 128.3759 in chronically infected cells. The difference between infected and uninfected cells was significant (P¼0.001) as determined by single-tailed Student's T-test (different variances). The higher total expression was also reflected in higher cell surface exposure of tetherin on infected cells as determined by FACS analysis (data not shown).
The enhanced expression of tetherin protein in infected cells correlated with higher levels of tetherin RNA. RT-qPCR analysis of the number of tetherin RNA molecules relative to the number of GAPDH RNAs also revealed a significant difference (P¼0.015); the average RNA level in six infected lines (MT2, MS9, MS68, C3669, C8166, Su68) was 49 726 molecules tetherin/1000 molecules GADPH while in uninfected samples (act. PBL, H9, CEM174, Molt4) the average level was 12.278.2 (Fig. 2B ). The numbers given here are from one of several independent experiments with similar results. These findings support the notion that HTLV-1 did not evolve the means to downregulate tetherin, but that tetherin levels are elevated even in the absence of exogenous interferon.
Tetherin severely decreases cell-free but not cell-cell transmission of HTLV-1
The previous sets of experiments predict that tetherin should restrict HTLV-1 cell-free infection, while the effect on cell-cell transmission cannot be easily anticipated. We used the recently developed HTLV-1 replication dependent reporter system to measure cell-cell transmission (Mazurov et al., 2010) . The reporter construct pCMVRU5-inluc is based on similar vectors developed to study the transmission of endogenous viruses and retrotransposons (Curcio and Garfinkel, 1991; Heidmann and Heidmann, 1991; Moran et al., 1996) (Fig. 3A ). pCMVRU5-inluc carries all the necessary cis acting elements of HTLV-1, but most of the coding sequences have been replaced by a firefly luciferase (luc) expression cassette inserted in anti-sense orientation into the retroviral transcription unit. The retroviral transcript vector contains an intron located in the luc gene, in such a way that it can be spliced from the viral transcript but disrupts the open reading frame on the luc RNA. Thus, luciferase is only expressed after the retroviral vector transcript has been spliced, packaged with components provided by the cotransfected packaging construct, transferred to a target cell, reverse transcribed, integrated and the now uninterrupted luc gene has been transcribed. We first wanted to determine the effect of tetherin on overall transmission of HTLV-1 in HEK293T cells. We cotransfected the pCMVRU5-inluc plasmid, the full-length pCMVHT-1M packaging construct and increasing amounts of the myc-tetherin expression construct into HEK293T cells and incubated the cells 48 h prior to lysis and determination of luciferase activity. The infectivity in this experiment is a combination of cell-free as well as cell-cell transmission and showed a gradual decrease from 80 to 35% of the no tetherin control sample with increasing amounts of tetherin ( Fig. 3B , black line). To determine the effect of tetherin on the cell-free transmission in these cultures, we harvested the supernatants just prior to lysis and transferred them to fresh HEK293T cells, which were then incubated for 48 h. Even the smallest amount of tetherin drastically decreased the amount of infectious virus in the supernatant resulting in a more than tenfold reduction of luciferase activity in the infected culture compared to the no tetherin control (Fig. 3B , cell-free -gray line). This result indicates that most of the transmission in the first part of the experiment occurred cell-cell.
To verify these results we analyzed cell-free and cell-cell transmission in two additional ways. To confirm the inhibitory effects on cell-free transmission we co-transfected the conventional single cycle reporter construct pCMVRU5-GFPluc, the pCMVHT-1M packaging plasmid and increasing amounts of the myc-tetherin construct, harvested the supernatants and transferred them to HeLa cells. The results of these experiments were very similar to those obtained in the cell-free arm of the previous experiments, in that we again saw a very steep decline in the infectivity of the particles even with minimal tetherin input ( Fig. 3C, left panel) . Western blot analysis of the pelleted supernatants from this experiment showed that the quantity of particles released into the supernatant inversely correlated with the amount of tetherin plasmid transfected ( Fig. 3C, right panel) .
Next, we used the Jurkat-Raji cell-cell transmission assay with the replication dependent pCMVRU5-inluc vector system to Samples were run in duplicate on two gels and blots were probed either with rabbit anti-tetherin or with mouse monoclonal anti-tubulin. The amount of tetherin relative to the amount of tubulin in each sample was determined by densitometry and graphed and the averages (arithmetic means) and standard deviations for uninfected and infected samples are shown. The difference between the two sample sets is significant (P ¼ 0.001 (Student's T-test, single tailed, different variances)). (B) Comparison of tetherin RNA expression in a subset of the panel of cell lines used in (A). polyA RNA was isolated from the indicated cell lines and RT-qPCR measurements were performed for tetherin and GAPDH sequences. The graph (aligned to the one in A for comparison) shows the number of tetherin RNAs/1000 GAPDH RNAs. No significant amplification was observed without reverse transcription. The averages and standard deviations for the infected and uninfected cells are given, and the difference in tetherin RNA expression between the two sets is significant (P ¼0.015).
confirm the effect of tetherin on cell-cell transmission. We have previously shown that infection with HTLV-1 from the transfected Jurkat cells to Raji cells is almost entirely dependent on cell-cell transmission as Raji cells are almost completely refractory to infection by cell-free virus and Jurkat cells are a poor target cell for either mode of transmission (Mazurov et al., 2010) . Again, we transfected the retroviral vector plasmids with increasing amounts of the tetherin plasmid and measured the cell-cell transmission to Raji cells added 24 h later. As in the cell-cell infection arm of the 293 T experiment, the impact of tetherin was mild; the amount of tetherin that was sufficient to reduce cellfree infection tenfold, had almost no effect on cell-cell transmission (Fig. 3D, left panel) . However, at the highest concentration of tetherin we did observe a significant drop of transmission of HTLV-1.
We analyzed the consequences of tetherin expression on Gag accumulation in supernatants and cell extracts by ELISA and found that the amount of anti-p19 reactive material in the supernatant declined sharply with the smallest addition of tetherin but remained constant in the cell extracts ( Fig. 3D, right panel) .
To confirm these results, we measured the effect of induction of tetherin expression by interferon-a (IFN-a) treatment on HTLV-1 transmission from Jurkat to Raji cells. Jurkat cells, transfected with retroviral vector plasmids, were treated with different concentrations of IFN-a, washed and mixed with Raji target cells. Fig. 3E (right panel) shows that although the level of the endogenous tetherin in the Jurkat cells increased several fold in response to the IFN-a treatment, cell-cell transmission was only decreased by 40-50% (Fig. 3E, left panel) .
In summary, even small amounts of tetherin severely reduced the release of virus particles from the surface of producer cells and limited cell-free infectivity of HTLV-1, while cell-cell transmission was significantly less impacted.
Tetherin does not facilitate cell-cell transmission
Several previous reports have shown that HTLV-1 buds in a polarized fashion (reviewed in Nejmeddine and Bangham, 2010) and virus release is redirected to the cell-cell contact area after interaction with the target cell. We tested whether tetherin and viral proteins are polarized to the site of cell-cell contact by immunofluorescence. As reported before (Pais-Correia et al., 2010) , we also observed the colocalization of Gag and tetherin by immunofluorescence and saw the apparent polarization of both Gag and tetherin to the site of cell-cell contact (Fig. 4) . We hypothesized that rather than inhibiting cell-cell transmission of HTLV-1, tetherin actually enhances it based on this evidence and the following findings:
(1) exogenous tetherin only marginally restricted cell-cell transmission even in Jurkat cells, which normally express tetherin; (2) the study by Pais-Correia et al. (2010) showed that tetherin is part of a biofilm like structure that enhances HTLV-1 transmission, (3) as shown above, HTLV-1 infected cells have higher than normal tetherin levels (Figs. 2 and 4) the gradual decrease of cell-cell infection observed in our experimental models was probably due to the overexpression of tetherin (beyond physiological level). If the hypothesis were true, then the tetherin expressed in Jurkat cells should support HTLV-1 transmission, and silencing it with shRNA should reduce cell-cell transmission. We generated pools of KD-tetherin Fig. 3 . Tetherin severely decreases cell-free transmission but not cell-to-cell infection. (A) Cartoon showing the replication-dependent HTLV-1 reporter vector pCMVRU5-inluc, which contains firefly luciferase (luc) expression cassette transcribed in opposite orientation relative to the retroviral genomic RNA. The luc gene is interrupted by a DNA sequence that functions as an intron on the retroviral vector transcript, but has no functionality on the luc mRNA. Thus, transcription, splicing, packaging, infection, reverse transcription and integration are required to generate an uninterrupted luc gene. (B) HEK293T cells were transfected with HTLV-1 packaging plasmid pCMVHT1-M, pCMVRU5-inluc reporter vector and the indicated amounts of plasmid expressing WT tetherin. After 24 h the media were changed, after additional 24 h the supernatants were collected and the cells were lysed. Luciferase activity in the cell lysate was determined as a measure of total transmission in this culture (black line). The supernatants were transferred to fresh HEK293T cells to measure the amount cell-free infectious virus. The cultures were lysed 48 h after infection and luciferase activity was measured (gray line). X-axis represents the amount of transfected tetherin plasmid (mg). Y-axis represents the relative infectivity, where 100% is viral transmission in the absence of transfected tetherin. (C) Cell-free infectivity assay. Left panel: HEK293T cells were transfected with 1 mg HTLV-1 packaging plasmid, 3 mg pCMVRU5-GFPluc reporter vector and the indicated amounts of plasmid expressing WT tetherin. After 48 h, media were collected and transferred to HeLa cells. The HeLa cells were lysed after 48 h and luciferase activity was determined as a measure of infection. Jurkat cells using lentiviral vectors encoding a puromycin resistance marker and either a control shRNA sequence or shRNAs targeting different sequences in the tetherin gene. Following selection for puromycin resistance, knockdown of tetherin was evaluated based on the surface expression of tetherin by FACS analysis. We identified cell pools derived from two shRNAs sequences that had at least a tenfold reduction of tetherin expression and we used these cells to measure the effect of tetherin knock down on cell-cell transmission (Fig. 5A) . The Jurkat-KD-tetherin cells showed a slight increase (42%) in HTLV-1 transmission to Raji cells indicating that tetherin has a small inhibitory effect on cell-cell transmission (Fig. 5B) . While there is a component of cell-free transmission even in this system, it is less than 10% of the total infection (Mazurov et al., 2010) .
Discussion
Eukaryotic cells have evolved a variety of innate mechanisms to inhibit virus replication. Viruses that have successfully established themselves in a given host species, have acquired ways to overcome these host defenses. The recently discovered tetherin is a restriction factor that prevents release of mature particles of a variety of enveloped virus species and belongs to the cellular defense system. One hallmark, which identifies a cellular component as a viral restriction factor, is that viruses evolve functions to counteract it.
In this study, we set out to address the question whether HTLV-1 has evolved a way to overcome the tetherin barrier. We did not find evidence for any tetherin antagonist that acts in a fashion comparable to Vpu, Nef or Env in the different lentiviruses. Previous studies have shown that HTLV-1 Gag VLPs are susceptible to retention on the cell surface (Jouvenet et al., 2009) and we found that cell-free transmission of infectious virus in in vitro assay systems is also severely restricted. However, most retroviruses have been shown to be significantly more infectious when transmission can occur cell-cell rather than cell-free. This is especially the case for HTLV-1, whose epidemiological profile suggests that cell-free transmission is all but impossible in vivo. Several modes of cell-cell transmission with different retroviruses have been described based on microscopical observation and a priori it is not clear whether tetherin would interfere with this mode of transmission or actually enhance it.
Transmission of a retrovirus through the VS was first described for HTLV-1 and later also demonstrated to occur with other retroviruses . The VS is a relative tight juxtaposition of the membranes of the effector and the target cells initiated by the binding between Env and the receptor along with engagement of ICAM-1 and LFA-1, respectively. The tight space between the two cells is barely wide enough to accommodate one particle easily allowing the particle budding from the producer cell to reach and fuse with the target cell (Hubner et al., 2009; Nejmeddine et al., 2009) . Tetherin should only inhibit this mode of transmission, if the tetherin molecules on the viral particles posed a hindrance to fusion. In addition to the VS, which involves a relatively large area of cell surface, transmission via contacts at the end of membrane nanotubes involving similar but significantly smaller areas has been described. The HTLV-1 accessory protein p8 has been reported to induce this type of structures (Van Prooyen et al., 2011) . Viruses are thought to move along these nanotubes until they encounter the target cell. It is not clear whether tetherin would impede this movement.
Recently, a report by Pais-Correia et al. (2010) suggested that for HTLV-1 the adherence between cells only serves to keep the Fig. 4 . Tetherin and Gag colocalize in the cell-cell contact area. Jurkat cells were loaded with calcein-blue (CB), mixed with MS9 cells and incubated for 30 min. Cells were adhered to poly-Lysine coated slides, fixed, permeabilized and probed with anti-tetherin and anti-p19MA antibodies. cells in close proximity to facilitate the transference of so-called viral assemblies from the donor to the target cell. Viral assemblies are the consequence of the polarized release of viruses, which are caught up in a biofilm-like network of glycosylated proteins. Tetherin is one component of these glycosylated proteins in viral assemblies, which enhance the infectivity of the virus mainly due to the delivery of a high dose of virus at a time.
Three studies have evaluated the effect of tetherin on cell-cell transmission of Vpu deficient HIV-1; two groups reported relatively small inhibitory effects of tetherin on cell-cell transmission (20 to 50%) (Casartelli et al., 2010; Kuhl et al., 2010) , while the third group observed an about twofold increase in the presence of tetherin (Jolly et al., 2010) . Although somewhat contradictory, taken together the three studies show that the effect of tetherin on cell-cell transmission of HIV-1 is significantly less profound than on cell-free transmission.
Our results also suggest that the impact of tetherin on HTLV-1 cell-cell transmission in our Jurkat-Raji system is relatively small. Cell-cell transmission is reduced less that twofold at low and intermediated concentrations of tetherin that are sufficient to inhibit cell-free transmission more than twentyfold. Furthermore, we saw a modest increase (42%) in cell-cell infection after knock down of tetherin in Jurkat cells indicating that tetherin has a small inhibitory effect. Conversely, we saw only twofold or lower inhibition after introducing low to moderate amounts of exogenous tetherin by transfection or after inducing the expression of endogenous tetherin by IFN-a treatment; only high overexpression of tetherin resulted in a pronounced drop in cell-cell transmission. While we are able to measure cell-cell transmission accurately, our system is limited by the effector and target cells that function in our assay (Mazurov et al., 2010) . However, it seems clear that, at least in this system, tetherin in the context of viral assemblies does not contribute a beneficial effect.
The interplay of the innate cellular immunity and HTLV-1 is complex and not well understood yet (Journo and Mahieux, 2011) . While there is evidence that the system is activated in chronically infected lines based on elevated expression of IFN-g (Smith et al., 1999) , it is also documented that Tax and HBZ deregulate the signaling pathways of cellular immunity (Charoenthongtrakul et al., 2011; Mukai and Ohshima, 2011) . We found that tetherin expression and cell surface presentation were significantly higher in chronically infected T-cell lines than in uninfected transformed CD4 þ T-cell lines or CD3/28 stimulated PBLs. This was not caused by higher levels of IFN-a in the infected cells, as all cell lines expressed comparable and very low levels of IFN-a (data not shown). However, recent studies by Bego et al. (2012) showed that the tetherin gene BST2, like the IFN-a genes, is activated as part of the early intrinsic immune response and its expression can be maintained in the absence of IFN-a. Thus it seems likely that chronically infected cells express elevated levels of tetherin unless the virus is able to induce its downregulation. Even for HIV-1, higher levels of tetherin in chronically infected than in noninfected cells have been reported (Homann et al., 2011) .
Recent studies by Tattermusch et al. (2012) demonstrated that IFN-1 inducible genes are more highly transcribed in the white blood cells of patients with HAM/TSP and that the level of induction of these genes is highly correlated with the severity of the disease. Although the upregulation of these genes was more pronounced in monocytes and neutrophils than in CD4 þ or CD8 þ T-lymphocytes in the patients, the CD4 þ cells displayed expression markers indicating an activated state of intrinsic immune response suggesting that BST2 would also be partially activated in these cells as part of the intrinsic immune response.
Conclusion
We have found that tetherin in concentrations that severely restricted release of HTLV-1 particles caused a slight inhibition on HTLV-1 cell-cell transmission, which is the major mode of HTLV-1 infection.
Materials and methods
Cell culture
Human kidney HEK293T cells and human cervical carcinoma HeLa cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and L-glutamine. Human Jurkat E6-1 cells (obtained from the American Type Culture Collection and the AIDS Research and Reference Reagent Program, respectively) and Raji/CD4 cells (provided by Vineet N. KewalRamani, NCI) were grown in RPMI-1640 medium containing 10% fetal bovine serum and L-glutamine. The HTLV-1 immortalized cell lines MS9 and MS64 were obtained by coculture of activated human peripheral blood mononuclear cells with HEK293T cells transfected with the HTLV-1 provirus clone pHTLV-X1MT (Shuh et al., 1999) were maintained in RPMI-1640 medium supplemented with 15% fetal bovine serum, L-glutamine and 100 U/ml recombinant interleukin 2 (IL-2). Cell lines HuT102, MT2, C8166, cl3669 and Su68 have previously been described (Mitchell et al., 2007) . The following cell lines were obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: MT2 (cat #237) from Dr D. Richman, C8166 (cat #404) and H9 (cat#87) from Dr. R. Gallo, HUT78 (cat #87) from Dr. A. Gazdar and Dr. R. Gallo. HUT 102 is described elsewhere (Poiesz et al., 1980a) . Peripheral blood lymphocytes (PBL) were prepared from elutriated lymphocytes and stimulated with agarose beads coated with anti-CD3 and anti-CD28 antibodies (Life-Technologies) as described by the manufacturer and cultured for 7-10 days prior to harvest.
Plasmids
The HTLV-1 packaging plasmid pCMVHT1-M expresses all HTLV-1 gene products and has been described. The HTLV-1 reporter plasmid pCMVRU5-GFPluc (Derse et al., 2001; Hill et al., 2003) , which was used in cell-free infections, was derived from pHTC-GFPluc by joining the CMV promoter to the RU5 region of the 5 0 LTR at the TATA box. For single-cycle cell-cell infections, we created the reporter plasmid pCMVRU5-inluc; the reporter cassette within pCMVRU5-GFPluc was replaced with a cassette containing the CMV promoter, luc gene (with g-globin intron), and TK polyA signal (Mazurov et al., 2010) . The CMV-inluc-TK polyA cassette is oriented in the opposite direction relative to viral vector transcription, but the intron is oriented in the sense direction. The Myc-tagged tetherin expression plasmid was provided by Bieniasz (Neil et al., 2008; Perez-Caballero et al., 2009) . pcDNAVphu was obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from Dr. Stephan Bour and Dr. Klaus Strebel (Nguyen et al., 2004) .
Transfections and immunoblotting
HEK293T cells (1.2 Â 10 6 cells per 60 mm dish) cells and HeLa cells (1.5 Â 10 6 cells per 60 mm dish) were transfected using TransIT s -293 (MIRUS) and FuGene (Roche), respectively, according to the manufacturers' protocols. Media was changed after 6 h and 24 h after transfection samples were collected. VLPs were concentrated by ultracentrifugation, viral pellets were dissolved in NUPAGE LDS sample buffer with reducing reagent (Invitrogen) and heated for 7 min at 90 1C. Cells were lysed in TNT buffer (1% Triton X-100, 10 mM Tris-Cl, pH 7.4, 150 mM NaCl, 1 mM EDTA) for 1 h on ice and samples were prepared as for VLPs. Cell and VLP extracts were fractioned by SDS-PAGE and transferred to Immobilon membrane. Equal loading of proteins was monitored by staining the membranes with Ponceau S solution (Sigma) or probing for tubulin (mAB anti-tubulin, Sigma). Blots were probed with anti-HTLV1-p19MA from ZeptoMetrix Corporation, anti-Myc (Cell Signaling Technology), anti-tetherin (AIDS reagent program) or anti-tubulin (Sigma). Membranes were blocked with 5% nonfat milk in PBS with 0.02% Tween (Sigma) (PBST), probed with primary antibodies, washed with PBST and developed with HRPconjugated secondary antibodies (Cell Signaling). Blots were washed again, and immunoreactive bands were detected with ChemiGlow Reagent on an AlphaImager (Alpha Innotec); the signal intensity was determined to to quantify protein levels. Statistical analysis was done using Student's T-test (one-tailed, unequal variance).
Real-time PCR
Real-time PCR and analysis of cDNA amplification products were performed as previously described (Princler et al., 2003) . The primer sequences used were: TETH-F2 CACCATCAAGGCCAA-CAG and TETH-R2 CCATCACAGTGTGGTTGC.
Infection assays
Single-cycle replication assays to quantify cell-free infection with HTLV-1 vectors have been described previously . Briefly, cell-free infections were performed by transfecting HEK293T cells with packaging plasmid (pCMVHT1-M), reporter plasmid (pCMVRU5 inluc or pCMVRU5-GFPluc), and tetherin expression plasmid. Twenty four hours after transfection media were changed and after additional 24 h the supernatants were filtered, added to 293 T or HeLa cells, respectively, and luciferase activity was measured 48 h later using Promega BrightGlo luciferase reagent and Lumat LB9501 luminometer (Berthold). Cellcell infections were performed by transfecting Jurkat cells (2 Â 10 6 cells/well in a 12-well plate) with pCMVHT1-M packaging vector, pCMVRU5-inluc reporter vector, and tetherin expression plasmid using TransIT s -Jurkat (Mirus) transfection reagent. The following day, cells were washed with PBS and mixed with an equal number of Raji-CD4 þ cells in complete RPMI. After 48 h cells were collected, lysed and luciferase activity was measured as above. For one-step infection assays (combined cell-free and cellcell) HEK293T cells were transfected with pCMVHT1-M packaging vector, pCMVRU5-inluc reporter vector, and tetherin expression plasmid. Media were changed after 24 h and after additional 24 h cells were collected and lysed after 48 h; luciferase activity was determined as above.
shRNA silencing shRNAs (Openbiosystem, cat number: RHS4533, clones TRCN0000107019 and TRCN0000107018) directed against the tetherin/BST2 were used to silence tetherin in Jurkat cells. shRNA was delivered to Jurkat cells through lentivirus infection according the manufacturer's protocol. Puromycin (2 mg/ml) was used for selection.
FACS analysis of tetherin surface expression
Jurkat cells were collected and probed with anti-tetherin antibody (obtained from the AIDS Research and Reference Reagent Program, NIH, cat# 11722 from Drs. Klaus Strebel and Amy Andrew) in PBS containing 1% BSA on ice. Goat anti-rabbit IgG-PE (BD) was used as secondary antibody. Samples were analyzed on a FACS Calibur (BD).
Confocal microscopy
Jurkat cells (1 Â 10 6 ) were stained with calcein blue (Molecular Probes) according a manufactured protocol and mixed with MS9 cells. After 30 min, cells were seeded on polylysine coated cover slips for additional 30 min. Cells were fixed with 2% paraformaldehyde, and incubated with rabbit anti-tetherin antibody (obtained from the AIDS Research and Reference Reagent Program, NIH) in PBS containing 1% BSA. Goat anti-rabbit antibody conjugated with Alexa Fluor 488 was used for staining. Cells were permeabelized and probed with anti-p19MA (ZeptoMetrix Corporation) antibody. Alexa Fluor 594-conjugated anti-mouse antibody was used for staining. Slides were maintained in Pro-Long Antifade reagent and analyzed on a Zeiss LSM 510 Inverted Laser Scan.
